Matches in Wikidata for { <http://www.wikidata.org/entity/Q92846465> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92846465 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92846465 description "scientific article published on 22 August 2019" @default.
- Q92846465 description "wetenschappelijk artikel" @default.
- Q92846465 description "наукова стаття, опублікована 22 серпня 2019" @default.
- Q92846465 name "Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)" @default.
- Q92846465 name "Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)" @default.
- Q92846465 type Item @default.
- Q92846465 label "Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)" @default.
- Q92846465 label "Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)" @default.
- Q92846465 prefLabel "Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)" @default.
- Q92846465 prefLabel "Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)" @default.
- Q92846465 P1433 Q92846465-F92AE8B8-532C-4208-B375-12E30634EDFD @default.
- Q92846465 P1476 Q92846465-C986C4BE-3C27-4FEC-A7EB-5A988D33AB94 @default.
- Q92846465 P2093 Q92846465-05A12A09-8777-4E8E-A21C-74A6D6BF74CE @default.
- Q92846465 P2093 Q92846465-18F30EF3-1BBE-402F-A1BB-1234B8556AE7 @default.
- Q92846465 P2093 Q92846465-231E1A9A-0952-44D0-8292-798353080E11 @default.
- Q92846465 P2093 Q92846465-32D1DAA5-CC48-488B-A91E-57696FAB2B99 @default.
- Q92846465 P2093 Q92846465-39DC881F-5D25-40E9-B367-C03BEA2A661E @default.
- Q92846465 P2093 Q92846465-3CBD13A4-0C2A-4E8D-ABC3-409D59799C2D @default.
- Q92846465 P2093 Q92846465-89CE77A7-E082-45D6-B390-A8E94801975E @default.
- Q92846465 P2093 Q92846465-A4BBCD93-98BE-41B7-BA8A-B7BA175FCF07 @default.
- Q92846465 P2093 Q92846465-CC4691E9-F2D3-4DC6-9206-9E70EF88E492 @default.
- Q92846465 P2093 Q92846465-FC27AF6D-7852-427E-876C-EC71380736B5 @default.
- Q92846465 P2093 Q92846465-FC7D5C38-6EF7-4C86-A36F-573CB4934F68 @default.
- Q92846465 P304 Q92846465-C0D37DA4-45CC-471C-905C-AA18FB1308D2 @default.
- Q92846465 P31 Q92846465-667E2178-DCDF-4268-AF45-B384A42645A5 @default.
- Q92846465 P356 Q92846465-70E0EFEE-4E0A-464B-96D2-7D23B184D97C @default.
- Q92846465 P478 Q92846465-7B45848E-3E32-4C9C-B2A4-EACFE7279EAA @default.
- Q92846465 P577 Q92846465-2D22AE68-66D0-4C3E-98E9-A6D7DA1B47AB @default.
- Q92846465 P698 Q92846465-A4D340F7-8127-4D6E-9A08-A73F09A3F883 @default.
- Q92846465 P921 Q92846465-EEC73E0C-3AEF-48B5-896C-1194F7BDFFE0 @default.
- Q92846465 P356 J.CCT.2019.105835 @default.
- Q92846465 P698 31446143 @default.
- Q92846465 P1433 Q5164971 @default.
- Q92846465 P1476 "Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)" @default.
- Q92846465 P2093 "Alan D Michelson" @default.
- Q92846465 P2093 "Anders R Berggren" @default.
- Q92846465 P2093 "Baba Inusa" @default.
- Q92846465 P2093 "Carl Amilon" @default.
- Q92846465 P2093 "HESTIA3 study investigators" @default.
- Q92846465 P2093 "Jessie Githanga" @default.
- Q92846465 P2093 "Julie Kanter" @default.
- Q92846465 P2093 "Maria Leonsson-Zachrisson" @default.
- Q92846465 P2093 "Marielle Andersson" @default.
- Q92846465 P2093 "Matthew M Heeney" @default.
- Q92846465 P2093 "Miguel R Abboud" @default.
- Q92846465 P304 "105835" @default.
- Q92846465 P31 Q13442814 @default.
- Q92846465 P356 "10.1016/J.CCT.2019.105835" @default.
- Q92846465 P478 "85" @default.
- Q92846465 P577 "2019-08-22T00:00:00Z" @default.
- Q92846465 P698 "31446143" @default.
- Q92846465 P921 Q269829 @default.